COVID-19: CDC, FDA and CMS Guidance

Apr 6, 2022
The Centers for Medicare & Medicaid Services (CMS) today released updated guidance for compliance with the agency’s COVID-19 vaccination requirement for health care staff.
Mar 28, 2022
AHA, hospital groups ask U.S. Department of Health and Human Services Secretary, Xavier Becerra, to renew the COVID-19 public health emergency (PHE).
Mar 25, 2022
The Centers for Disease Control and Prevention yesterday broadened its masking guidance, enabling visitors of health care facilities to wear N95 masks.
Mar 16, 2022
Pfizer asked the Food and Drug Administration to authorize a second booster dose of its COVID-19 vaccine for adults age 65 and older who received an initial booster of any authorized or approved COVID-19 vaccine, based on data from Israel showing the additional booster reduced infections and severe…
Mar 15, 2022
Weekly COVID-19-associated hospitalization rates among U.S. infants and children under age 5 have declined since peaking Jan. 8, but peak rates during omicron predominance were about five times those during delta predominance, the Centers for Disease Control and Prevention reported.
Mar 14, 2022
The Food and Drug Administration recently authorized extending from six to nine months the shelf life for refrigerated Johnson & Johnson COVID-19 vaccine stored at 2-8 degrees Celsius (about 36-46 degrees Fahrenheit), based on data submitted by the company. 
Mar 11, 2022
The Transportation Security Administration will continue to require masks on public transportation through April 18 to protect against COVID-19, as the Centers for Disease Control and Prevention recommends. 
Mar 11, 2022
In a study of 1,364 children aged 5-15, two doses of the Pfizer COVID-19 vaccine reduced the risk of omicron infection by 31% in those under 12 and 59% in older children, the Centers for Disease Control and Prevention reported.
Mar 11, 2022
Effective April 4, the Department of Health and Human Services will no longer require COVID-19 testing facilities to report negative results for tests authorized for use under a Clinical Laboratory Improvement Amendment certificate of waiver, the Centers for Disease Control and Prevention reports. 
Mar 10, 2022
An estimated 28% of children aged 5-11 received a first dose of the Pfizer COVID-19 vaccine between Nov. 1 and Jan. 18, while 19% received a second dose, according to a report released by the Centers for Disease Control and Prevention